Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


University of Hamburg

Latest From University of Hamburg

Polyganics Goes Shopping For Technology And Talent

The Netherlands-based biomaterials start-up intends to expand its platform's reach through strategic partnerships and tuck-in acquisitions.

Medical Device Business Strategies

Recent Financings of Private Companies (09/2008)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

Deals Shaping the Medical Industry (5/07)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Sequenom Inc.

Drug Discovery Tools; Genomics. Sequenom combines mass spectrometry, DNA conditioning chemistry, and a patented DNA chip to identify and analyze high volumes of DNA with great accuracy. The technology measures the molecular weight of DNA samples to reveal disease-causing molecules.

See All

Company Information

  • Industry
  • Academic and Research Institutions